Vedere Bio
ClosedBringing vision back to life.
Cambridge, United States · Founded 2020
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- vederebio.com
About
Vedere Bio II, Inc. was a Cambridge, Massachusetts-based biotechnology company developing next-generation ocular gene therapies for vision restoration and preservation in patients with vision loss due to photoreceptor death. Founded in 2020 by leaders of the original Vedere Bio (acquired by Novartis in 2020), the company raised $77M in Series A funding before winding down operations in April 2023.
Summary
Vedere Bio is a Biotech company based in Cambridge, United States, founded in 2020.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...